The current valuation score of Rafael Holdings Inc is 7.41, ranking 129 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -3.57, which is -678.87% below the recent high of 20.66 and -753.03% above the recent low of -30.44.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.